NEW YORK (GenomeWeb News) — A federal judge has agreed with Sigma-Aldrich and Oxford Biomedica’s definition of terms for RNAi-related intellectual property at the heart of a pending patent-infringement suit the companies filed against Open Biosystems last year, Sigma-Aldrich said today.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.